SS 01 - CNS 1: Novel Approaches in Brain Metastases

Presentations

• 02:30pm - 03:45pm PT

  CNS 1: Novel Approaches in Brain Metastases

  Speaker: Puyao Li, MD - University of Vermont Medical Center, Burlington
• 02:30pm - 03:45pm PT

  CNS 1: Novel Approaches in Brain Metastases

  Speaker: Hsiang-Hsuan Yu, MD, MS, FASTRO - Moffitt Cancer Center, Tampa
• 02:30pm - 02:40pm PT

  Multicenter, Phase 3 Randomized Trial of Stereotactic Radiation vs. Hippocampal Avoidance Whole Brain Radiation in Patients with 5-20 Brain Metastases: Recurrence, Salvage Therapy, and Mortality Endpoints

  Speaker: Ayal Aizer, MD - Brigham and Womens Hospital, Boston
• 02:40pm - 02:50pm PT

  Phase II Prospective Trial of Image-Guided Cognitive-Sparing Brain Radiosurgery (COG-SRS) with a Connectivity Approach: The Future of Functional Preservation

  Speaker: Andrew Puett, MD, PhD - UC San Diego Radiation Medicine and Applied Sciences, La Jolla
• 02:50pm - 03:00pm PT

  Effect of Early Integrated Neuropsychological Care in Patients with Brain Metastases: A Phase 2 Randomized Controlled Trial (ATHENA Trial)

  Speaker: Haley Perlow, MD - Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland
• 03:00pm - 03:10pm PT

  An Initial Report of Memory Avoidance Whole Brain Radiotherapy to Treat Brain Metastases: A Prospective Phase 2 Trial

  Speaker: Haley Perlow, MD - Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland
• 03:10pm - 03:20pm PT

  Deep Learning-Based Personalized Blood Dosimetry (OncoBlood) for Circulating Blood Cell Exposure Predicts Radiation-Induced Severe Lymphopenia and Survival Outcomes in Craniospinal Irradiation

  Speaker: Sang Hoon Seo, MD - Oncosoft, Seoul
• 03:20pm - 03:30pm PT

  Use of Gadolinium Nanoparticles as Radiosensitizers for Brain Metastases: Results from the Phase 2 Multicentric Randomized Trial (NANORAD2)

  Speaker: Camille Verry, MD - Centre Hospitalier Universitaire Grenoble Alpes, Grenoble
• 03:30pm - 03:40pm PT

  Prospective Interventional Study Investigating the Neurocognitive Effects and Quality of Life (QOL) in Patients with Brain Metastases, Comparing Hippocampal Avoidance Whole-Brain Radiation Therapy (HA-WBRT) with SIB to SRS/FSRT

  Speaker: Souvik Sankar Das, MBBS - Chittaranjan National Cancer Institute, Kolkata
• 03:40pm - 03:50pm PT

  Discussant

  Speaker: Jonathan Yang, MD, PhD - New York University School of Medicine, New York